schizandrin b has been researched along with nu 7026 in 1 studies
| Studies (schizandrin b) | Trials (schizandrin b) | Recent Studies (post-2010) (schizandrin b) | Studies (nu 7026) | Trials (nu 7026) | Recent Studies (post-2010) (nu 7026) |
|---|---|---|---|---|---|
| 321 | 1 | 218 | 70 | 0 | 44 |
| Protein | Taxonomy | schizandrin b (IC50) | nu 7026 (IC50) |
|---|---|---|---|
| Serine/threonine-protein kinase mTOR | Homo sapiens (human) | 6.4 | |
| DNA-dependent protein kinase catalytic subunit | Homo sapiens (human) | 0.2388 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Charrier, JD; Durrant, SJ; Golec, JM; Kay, DP; Knegtel, RM; MacCormick, S; Mortimore, M; O'Donnell, ME; Pinder, JL; Pollard, JR; Reaper, PM; Rutherford, AP; Wang, PS; Young, SC | 1 |
1 other study(ies) available for schizandrin b and nu 7026
| Article | Year |
|---|---|
Discovery of potent and selective inhibitors of ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase as potential anticancer agents.
Topics: Amino Acid Sequence; Antineoplastic Agents; Catalytic Domain; Drug Discovery; Models, Molecular; Molecular Sequence Data; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyrazines; Structure-Activity Relationship; Substrate Specificity; Sulfones | 2011 |